Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.
Ai L, Li Y, Zhou L, Yao W, Zhang H, Hu Z, Han J, Wang W, Wu J, Xu P, Wang R, Li Z, Li Z, Wei C, Liang J, Chen H, Yang Z, Guo M, Huang Z, Wang X, Zhang Z, Xiang W, Sun D, Xu L, Huang M, Lv B, Peng P, Zhang S, Ji X, Luo H, Chen N, Chen J, Lan K, Hu Y.
Ai L, et al. Among authors: xiang w.
Cell Discov. 2023 Jan 23;9(1):9. doi: 10.1038/s41421-022-00517-9.
Cell Discov. 2023.
PMID: 36683074
Free PMC article.